Planta Med 2010; 76(6): 572-582
DOI: 10.1055/s-0029-1240602
Pharmacology
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Cardiac and Electrophysiological Effects of Primary and Refined Extracts from Leonurus cardiaca L. (Ph.Eur.)

Malte Ritter1 [*] , Kerstin Melichar1 [*] , Sabine Strahler2 , Kenny Kuchta2 , Jan Schulte1 , Laura Sartiani3 , Elisabetta Cerbai3 , Alessandro Mugelli3 , Friedrich-Wilhelm Mohr1 , Hans Wilhelm Rauwald2 , Stefan Dhein1
  • 1Clinic for Cardiac Surgery, University of Leipzig, Leipzig, Germany
  • 2Department of Pharmaceutical Biology, University of Leipzig, Leipzig, Germany
  • 3Department of Pharmacology, University of Florence, Florence, Italy
Further Information

Publication History

received June 9, 2009 revised October 14, 2009

accepted October 18, 2009

Publication Date:
16 November 2009 (online)

Abstract

Although several antiarrhythmic drugs of chemical origin are in clinical use since decades, their application is often limited by their adverse effects and especially by their inherited proarrhythmic risk, which can lead to a significantly increased mortality in patients receiving these compounds. On the other hand, aqueous extracts from the aerial parts of the European Lamiaceae Leonurus cardiaca (Ph.Eur.) have been used for centuries as a remedy against tachyarrhythmia and other cardiac disorders. Nevertheless, a scientific basis for the claim of direct cardiac electrophysiological, antiarrhythmic, or functional effects of Leonurus cardiacae herba (LCH) preparations has not been established until now. In order to enrich the active constituents from the primary extract which was tested as the most cardioactive, namely the aqueous Soxhlet extract, and to eliminate undesired substances such as the dichloromethanic fraction or potassium, a bioassay guided fractionation procedure was applied, resulting in the development of a Leonurus cardiaca refined extract (LCRE) which was characterised together with Leonurus crude extracts by a newly developed gradient elution HPLC fingerprint analysis for separation and quantification of six major phenolics as well as by qNMR for determining the stachydrine content. This refined extract was applied intracoronarily in isolated rabbit hearts perfused according to the Langendorff technique. Mapping experiments with 256 electrodes on the heart surface showed a reduction of left ventricular pressure and an increase of relative coronary flow at concentrations of 1.0 and 2.0 mg/mL LCRE. Furthermore, the PQ-interval was prolonged and both the basic cycle length and the activation recovery interval increased. In addition, voltage-clamp measurements were performed on the following cell models in order to characterise the electrophysiological profile of LCRE: neonatal rat ventricular cardiomyocytes to investigate the effect on INa and ICa.L, sinoatrial node cells and ventricular myocytes isolated from adult guinea pigs to test effects on If and action potential (AP) duration, as well as HERG-transfected HEK 293 cells to analyse the influence on the IK.r. In these voltage clamp experiments LCRE exerted a calcium-antagonistic activity by ICa.L blockade, reduced the repolarising current IK.r, and prolonged the AP-duration, while INa was not affected. Although LCRE displayed only weak effects on the If amplitude and voltage dependence, it significantly prolonged the activation time constant of If. Thus, LCRE acts on multiple electrophysiological targets, specifically ICa.L, IK.r, and If, observed both at whole organ and single cell level.

References

  • 1 Barnes J, Anderson L A, Phillipson J D. Monograph motherwort. Herbal medicines. London; Pharmaceutical Press 2002: 354-356
  • 2 Arber A. Herbals: their origin and evolution. A chapter in the history of botany 1470 – 1670. Cambridge; Cambridge University Press 1938
  • 3 Wichtl M, Stahl-Biskup E. Herzgespannkraut – Leonuri cardiacae herba. Bracher F, Heisig P, Langguth P, Mutschler E, Rücker G, Scriba G, Stahl-Biskup E, Troschütz R Kommentar zum Europäischen Arzneibuch. Stuttgart; Wissenschaftliche Verlagsgesellschaft 2005: (19. Lfg.): 4.03/1833
  • 4 Orlandi E. Application of Leonurus cardiaca in therapy of children.  Lattante. 1950;  21 582-586
  • 5 Milkowska-Leyck K, Filipek B, Strzelecka H. Pharmacological effects of lavandulifolioside from Leonurus cardiaca.  J Ethnopharmacol. 2002;  80 85-90
  • 6 Gaedcke F, Steinhoff B. Herbal medicinal products. Boca Raton; CRC Press 2003: 26-27
  • 7 Schulz V, Hänsel R, Tyler V E. Rational phytotherapy. Berlin, Heidelberg; Springer Verlag 1998: 6-8
  • 8 Dhein S, Muller A, Gerwin R, Klaus W. Comparative study on the proarrhythmic effects of some antiarrhythmic agents.  Circulation. 1993;  87 617-630
  • 9 Bazett H C. An analysis of time relations of electrocardiograms.  Heart. 1920;  7 353-370
  • 10 Zhou Z, Gong Q, Ye B, Fan Z, Makielski J C, Robertson G A, January C T. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.  Biophys J. 1998;  74 230-241
  • 11 Ding W G, Toyoda F, Matsuura H. Blocking action of chromanol 293B on the slow component of delayed rectifier K(+) current in guinea-pig sino-atrial node cells.  Br J Pharmacol. 2002;  137 253-262
  • 12 Cerbai E, Giotti A, Mugelli A. Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes.  Br J Pharmacol. 1997;  120 667-675
  • 13 Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation.  FASEB J. 2002;  16 1114-1116
  • 14 Cerbai E, Crucitti A, Sartiani L, De P P, Pino R, Rodriguez M L, Gensini G, Mugelli A. Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes.  Cardiovasc Res. 2000;  45 388-396
  • 15 Knöss W, Zapp J. Accumulation of furanic labdane diterpenes in Marrubium vulgare and Leonurus cardiaca.  Planta Med. 1998;  64 357-361
  • 16 Erspamer V. Ricerche Farmacologiche sul Leonurus cardiaca L. e sul Leonurus marrubiastrum.  Arch Intern Pharmacodyn. 1948;  76 132-152
  • 17 Kozlova L M. On the phytochemistry of Leonurus quinquelobatus Gilib.  Farmatsiia. 1967;  16 23-26
  • 18 Strahler S. Erstmalige HPLC-Fingerprint-Analytik und Quantifizierung wirkungsrelevanter Phenylethanoide sowie weiterer phenolischer Marker in Herzgespannkraut (Leonuri cardiacae herba Ph.Eur.) unter besonderer Betrachtung dessen antiarrhythmischen Spezialextrakts [Diploma thesis]. Leipzig; University of Leipzig 2008
  • 19 Pennacchio M, Syah Y M, Ghisalberti E L, Alexander E. Cardioactive compounds from Eremophila species.  J Ethnopharmacol. 1996;  53 21-27
  • 20 Kartnig T, Gruber A, Menzinger S. Flavonoid-O-glycosides from the herbs of Leonurus cardiaca.  J Nat Prod. 1985;  48 494
  • 21 Pauli G F, Jaki B U, Lankin D C. Quantitative 1H NMR: development and potential of a method for natural products analysis.  J Nat Prod. 2005;  68 133-149
  • 22 Hoppe U, Brandt M, Michels G, Lindner M. L-type calcium channel recording. Dhein S, Mohr FW, Delmar M Practical methods in cardiovascular research. Berlin, Heidelberg, New York; Springer Verlag 2004: 324-354
  • 23 Polder H R, Weskamp M, Linz K, Meyer R. Voltage-clamp and patch-clamp techniques. Dhein S, Mohr FW, Delmar M Practical methods in cardiovascular research. Berlin, Heidelberg, New York; Springer Verlag 2004: 272-323
  • 24 Kikuchi K, Nagatomo T, Abe H, Kawakami K, Duff H J, Makielski J C, January C T, Nakashima Y. Blockade of HERG cardiac K+ current by antifungal drug miconazole.  Br J Pharmacol. 2005;  144 840-848
  • 25 DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers.  Pharmacol Res. 2006;  53 399-406
  • 26 Cerbai E, Barbieri M, Mugelli A. Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging.  Circulation. 1996;  94 1674-1681
  • 27 Grace A A, Camm A J. Voltage-gated calcium-channels and antiarrhythmic drug action.  Cardiovasc Res. 2000;  45 43-51
  • 28 Boyd R A, Giacomini J C, Giacomini K M. Species differences in the negative inotropic response of 1,4-dihydropyridine calcium channel blockers in myocardium.  J Cardiovasc Pharmacol. 1988;  12 650-657
  • 29 Sanguinetti M C, Jurkiewicz N K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.  J Gen Physiol. 1990;  96 195-215
  • 30 Hancox J C, Levi A J, Witchel H J. Time course and voltage dependence of expressed HERG current compared with native “rapid” delayed rectifier K current during the cardiac ventricular action potential.  Pflugers Arch Eur J Physiol. 1998;  436 843-853
  • 31 Zünkler B J. Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects.  Pharmacol Ther. 2006;  112 12-37
  • 32 El-Sherif N. The ventricular premature complex: mechanisms and significance – an update. Mandel J Cardiac arrhythmias. Philadelphia; J. B. Lippincott Co. 1987: 475-506
  • 33 Dhein S, Pejman P, Krusemann K. Effects of the I(K.ATP) blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion.  Eur J Pharmacol. 2000;  398 273-284
  • 34 Hondeghem L M, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.  Circulation. 2001;  103 2004-2013
  • 35 Hellestrand K J, Nathan A W, Bexton R S, Camm A J. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.  Am J Cardiol. 1984;  53 30B-38B
  • 36 DiFrancesco D. The contribution of the ‘pacemaker current (If) to generation of spontaneous activity in rabbit sino-atrial node myocytes.  J Physiol. 1991;  434 23-40
  • 37 Cerbai E, Barbieri M, Mugelli A. Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes isolated from hypertensive rats.  J Physiol. 1994;  481 585-591
  • 38 Janicsák G, Veres K, Kakasy A Z, Imre Máthé I. Study of the oleanolic and ursolic acid contents of some species of the Lamiaceae.  Biochem Syst Ecol. 2006;  34 392-396
  • 39 Makarov V G, Aleksandrova A E, Shikov A N, Shiler L V, Ryzhenkov V E. Experimental and clinical study of preparation iridol action on the central nervous system.  Eksp Klin Farmakol. 2006;  69 23-25
  • 40 Kubota S, Nakashima S. The study of Leonurus sibiricus L.: chemical study of the alkaloid (Leonurin) isolated from Leonurus sibiricus L. and pharmacological study of the alkaloid “Leonurin” isolated from Leonurus sibiricus L.  Nippon Yakurigaku Zasshi (Folia Pharmacologica Japonica). 1930;  11 153-167
  • 41 Gulabov A Z, Tchervenkova-Veleva V B. On the structure of alcaloids from Leonurus cardiaca L.  Travaux scientifiques – Chimie. 1970;  8 129-132

1 These two authors contributed equally.

Prof. Dr. Stefan Dhein

Clinic for Cardiac Surgery
University of Leipzig

Struempellstrasse 39

04289 Leipzig

Germany

Phone: + 49 34 18 65 16 51

Fax: + 49 34 18 65 14 52

Email: dhes@medizin.uni-leipzig.de

Prof. Dr. Hans Wilhelm Rauwald

Chair of Pharmaceutical Biology
University of Leipzig

Johannisallee 21–23

04103 Leipzig

Germany

Phone: + 49 34 19 73 69 51

Fax: + 49 34 59 73 69 59

Email: rauwald@rz.uni-leipzig.de